Treprostinil and Guggul: Interaction Details
- Treprostinil
- OrenitramTyvasoRemodulin +2 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Treprostinil and Guggul interaction:
Treprostinil
- Orenitram
- Tyvaso
- Remodulin
- Yutrepia
- Tyvaso DPI
Guggul
We don't have a drug information page for Guggul yet. Have a question about Guggul? Ask a pharmacist, free →
What Happens When You Take Treprostinil With Guggul
What can happen when they are taken together (rated Moderate)
Increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
In theory, taking guggul alongside agents could raise the risk of bleeding. In humans, guggul has been associated with greater fibrinolytic activity and with less hypercoagulability, an effect attributed to lower serum lipids.12
In vitro, guggul also suppressed aggregation.3 For this reason, caution is recommended when guggul is used together with antiplatelet agents.
The Treprostinil and Guggul Interaction, Explained
Treprostinil is used to treat pulmonary arterial hypertension, and it can slightly slow blood clotting by keeping from sticking together. Guggul is an herbal supplement that, in lab and small human studies, may do something similar. Taken together, they could add to your chance of bleeding or bruising.
This is a theoretical concern, based mostly on lab findings, not on proven cases. Watch for easy bruising, nosebleeds, bleeding gums, or unusually dark stools. Tell your pharmacist or doctor if you take guggul, and ask them before starting or stopping anything. Your care team can keep an eye on this and manage it.
Interaction: Possible bleeding risk () between treprostinil, a prostacyclin analog with aggregation and vasodilation, and guggul.
- Mechanism: Guggul has shown increased fibrinolytic activity, in vitro inhibition of platelet aggregation, and reduced hypercoagulability via lipid lowering.
- Evidence: Theoretical; no clinical bleeding reports documented. Onset delayed. Severity rated moderate.
- Management: Use caution with . Monitor bleeding time and signs and symptoms of excessive bleeding. Review other antithrombotic or agents. Counsel patients on bleeding precautions.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Treprostinil and Guggul Interact
The likely mechanism
Increased fibrinolytic activity, of aggregation, and reduced hypercoagulability as a result of reduced serum lipids
How to Manage the Treprostinil and Guggul Interaction
Your care team may simply watch more closely, since this concern is theoretical and can be managed.
- Keep taking your treprostinil as prescribed, and let your pharmacist and prescriber know you use guggul or any supplement.
- Your team may monitor you more closely, including checking bleeding time.
- Report signs of bleeding promptly: unusual bruising, nosebleeds, bleeding gums, blood in urine or stool, or black stools.
- Do not start or stop any medicine or supplement without talking to your care team first.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Treprostinil or Guggul need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
3 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease
In a controlled trial (n=40), fraction A of gum guggul (0.5 grams twice a day) increased serum fibrinolytic activity in healthy individuals by 22% within 24 hours and by 40% after one month. In patients with coronary artery disease, activity rose by 29.8% after 30 days.
These effects lasted for as long as guggul was given and tended to return to baseline once it was stopped (duration not given). Other studies have reported that prothrombin times returned to baseline 3 weeks after guggul was discontinued.1
-
Report 2 · Study title
Experimental and clinical studies on the effect of guggulu (Commiphora mukul) in hyperlipemia and thrombosis
In a controlled trial of crude guggul, coagulation time increased in 9 patients, of whom 6 were obese, 2 had ischemic heart disease, and 1 had cerebral thrombosis. This effect was thought to be directly related to the reduction in circulating lipids, which prevented hypercoagulability. Serum turbidity was also reduced to nearly normal levels.2
-
Report 3 · Study title
Inhibition of platelet aggregation by "guggulu" steroids
In vitro, guggul sterones E and Z, extracted from gum guggul, markedly inhibited aggregation induced by adenosine diphosphate (ADP), adrenaline, and .3
Treprostinil and Guggul: Common Questions
How serious is the Treprostinil and Guggul interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Treprostinil and Guggul interaction managed?
Your care team may simply watch more closely, since this concern is theoretical and can be managed. Keep taking your treprostinil as prescribed, and let your pharmacist and prescriber know you use guggul or any supplement. Your team may monitor you more closely, including checking bleeding time. Report signs of bleeding promptly: unusual bruising, nosebleeds, bleeding gums, blood in urine or stool… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Treprostinil and Guggul Interaction
Ask in your own words about taking Treprostinil and Guggul together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Bordia A & Chuttani SK: Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease. Indian J Med Res 1979; 70(Dec):992-996.
- Tripathi SN, Shastri VVS, & Scharya GVS: Experimental and clinical studies on the effect of guggulu (Commiphora mukul) in hyperlipemia and thrombosis. J Res Indian 1968; 2:140-154.
- Mester L, Mester M, & Nityanand S: Inhibition of platelet aggregation by "guggulu" steroids. Planta Med 1979; 37(4):367-369. PubMed
Other Serious Interactions of Treprostinil and Guggul
Also serious with Treprostinil
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Treprostinil
- Activated CharcoalMajor
- American HelleboreMajor
- American MistletoeMajor
- PiracetamMajor
- TyramineMajor
- Vitamin B6Moderate
- SodiumModerate
- Vitamin EModerate
- + 285 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.